a critique of trade4profits thesis, page-2

A The Primary safety objective of this trial was to assess the safety and tolerability of two doses of
CAVATAKT.
B Company was only allowed to inject a single tumour
C.All patients in the trial had late stage disease and had previously failed or rejected standard
therapies.
D. Viralytics will use this report as a core source of data in the generation of its US FDA
Investigational New Drug (IND) filing.

I'm happy you get to show off wikipedia studies Ousia but you're no psychologist or trader. The market would have traded exactly the same without a single t4p post.